Centinel Spine Announces prodisc C Clinical Trials

Centinel Spine announced Investigational Device Exemption approval from FDA to initiate a two-level clinical trial with prodisc® C Vivo and prodisc C SK anterior cervical total disc replacement devices (TDRs).

The two-level prospective, randomized study will evaluate the devices at multiple sites throughout the U.S., comparing them to an...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0